Global Vaccine Adjuvants Market Growth 2023-2029

Global Vaccine Adjuvants Market Growth 2023-2029

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
LPI (LP Information)' newest research report, the “Vaccine Adjuvants Industry Forecast” looks at past sales and reviews total world Vaccine Adjuvants sales in 2022, providing a comprehensive analysis by region and market sector of projected Vaccine Adjuvants sales for 2023 through 2029. With Vaccine Adjuvants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Adjuvants industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Adjuvants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine Adjuvants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vaccine Adjuvants market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Adjuvants and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Adjuvants.
The global Vaccine Adjuvants market size is projected to grow from US$ 834.3 million in 2022 to US$ 1558.3 million in 2029; it is expected to grow at a CAGR of 1558.3 from 2023 to 2029.
The top 5 global manufacturers of vaccine adjuvants are GSK, CSL Limited, Croda, SEPPIC, Novavax, which have a combined market share of about 55 percent. North America is the largest market, with a share about 38%, followed by Europe and Asia Pacific with the share about 27% and 22%.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Adjuvants market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Aluminum Adjuvant
Emulsions Adjuvant
Others
Segmentation by application
Human Vaccine
Veterinary Vaccine
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
CSL Limited
Croda
SEPPIC
Novavax
SPI Pharma
Phibro
SDA BIO
Invivogen
Tj Kaiwei
OZ Biosciences
Brenntag Biosector
MVP Laboratories
Zhuoyue
Aphios
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vaccine Adjuvants market?
What factors are driving Vaccine Adjuvants market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccine Adjuvants market opportunities vary by end market size?
How does Vaccine Adjuvants break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.